GEODE CAPITAL MANAGEMENT, LLC
Position in DMAA — Drugs Made In America Acquisition Corp.
CIK 1214717
BOSTON, MA
Position in DMAA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$652,621
+$179,069 QoQ
Shares Held
62,273
+36.4% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 39 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DMAA Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $44,768,279 across 67 Shell Companies names. DMAA ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XXI |
Twenty One Capital, Inc.
|
4,051,834 | $25,931,737 | |
| 2 | MBAV |
M3-Brigade Acquisition V Corp.
|
90,428 | $971,196 | |
| 3 | KFII |
K&F Growth Acquisition Corp. II
|
83,571 | $871,645 | |
| 4 | NMP |
NMP Acquisition Corp.
|
80,955 | $822,502 | |
| 5 | SOCA |
Solarius Capital Acquisition Corp.
|
76,097 | $773,906 | |
| 6 | CEPF |
Cantor Equity Partners IV, Inc.
|
74,080 | $754,875 | |
| 7 | IPCX |
Inflection Point Acquisition Corp. III
|
65,591 | $670,012 | |
| 8 | DMAA |
Drugs Made In America Acquisition Corp.
This page
|
62,273 | $652,621 |
All Filings in DMAA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $652,621 | 62,273 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $473,552 | 45,648 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $468,804 | 45,648 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $465,609 | 45,648 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $455,529 | 45,462 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||